EudraVigilance Medicinal Product Dictionary (EVMPD) MCQs With Answer is a focused practice set for B. Pharm students covering EVMPD structure, Medicinal Product Identifier (MPID), product attributes (trade name, strength, pharmaceutical form, route), controlled vocabularies, ATC classification, and role in pharmacovigilance. This guide explains regulatory use by EMA and national competent authorities, data submission and maintenance by marketing authorization holders (MAHs), links to ICSRs/PSURs, and the transition towards ISO IDMP and SPOR standards. Clear explanations and applied questions will strengthen your understanding of product identification, reporting workflows, and data quality requirements essential for drug safety and regulatory affairs. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary purpose of the EVMPD within the EudraVigilance system?
- A centralized EU database of medicinal product information for pharmacovigilance
- A clinical trials registry for investigational drugs
- A manufacturing quality (GMP) oversight database
- A pricing and reimbursement database for medicines
Correct Answer: A centralized EU database of medicinal product information for pharmacovigilance
Q2. Who maintains and operates the EudraVigilance and EVMPD at the European level?
- European Medicines Agency (EMA)
- World Health Organization (WHO)
- US Food and Drug Administration (FDA)
- European Central Bank
Correct Answer: European Medicines Agency (EMA)
Q3. What does MPID stand for in the context of EVMPD?
- Medicinal Product Identifier
- Market Product Information Document
- Marketing and Pharmacovigilance ID
- Master Product Index Data
Correct Answer: Medicinal Product Identifier
Q4. Which of the following data elements is typically captured in an EVMPD product record?
- Trade name, active substance, strength, and pharmaceutical form
- Detailed patient-level adverse event narratives
- Manufacturing site floor plans
- Pricing and reimbursement codes
Correct Answer: Trade name, active substance, strength, and pharmaceutical form
Q5. How does EVMPD support Individual Case Safety Reports (ICSRs)?
- By providing standardized product identifiers and attributes for consistent reporting
- By storing full clinical trial data for every adverse event
- By replacing the need for spontaneous adverse event submission
- By issuing safety alerts directly to patients
Correct Answer: By providing standardized product identifiers and attributes for consistent reporting
Q6. Which stakeholders are expected to provide and maintain product data in EVMPD?
- Marketing authorization holders (MAHs) and applicants
- Individual patients
- Hospital pharmacists only
- Clinical trial volunteers
Correct Answer: Marketing authorization holders (MAHs) and applicants
Q7. What is the role of controlled vocabularies in EVMPD?
- To ensure consistent and interoperable product descriptions across reports and systems
- To allow free-text descriptions without standardization
- To limit entries to a single language only
- To obscure active substances for confidentiality
Correct Answer: To ensure consistent and interoperable product descriptions across reports and systems
Q8. Which classification code commonly appears in EVMPD records to classify therapeutic use?
- ATC code (Anatomical Therapeutic Chemical)
- ICD-10 diagnosis code
- UN/NAICS industry code
- ISBN book code
Correct Answer: ATC code (Anatomical Therapeutic Chemical)
Q9. EVMPD data are primarily used for which regulatory activity?
- Pharmacovigilance and safety signal management
- Assessing manufacturing GMP compliance on site
- Conducting price negotiations with payers
- Recruiting investigators for clinical trials
Correct Answer: Pharmacovigilance and safety signal management
Q10. Which statement best describes the scope of EVMPD?
- It stores standardized medicinal product information used in EU safety reporting
- It is a global medicines registry maintained by WHO
- It contains raw adverse event narratives from patients
- It tracks sales volume and market share for medicines
Correct Answer: It stores standardized medicinal product information used in EU safety reporting
Q11. How is product identity most reliably linked across systems in EVMPD?
- Using the unique MPID assigned to each product record
- Using the marketing authorization holder’s email address
- Using the brand’s logo image
- Using free-text product descriptions only
Correct Answer: Using the unique MPID assigned to each product record
Q12. Which of the following is TRUE about EVMPD updates?
- MAHs must update product records when key attributes change (e.g., strength, formulation)
- Product records are static and never updated after creation
- Only national authorities can edit MAH-submitted records
- Updates are only required if a safety signal is detected
Correct Answer: MAHs must update product records when key attributes change (e.g., strength, formulation)
Q13. Which information is generally NOT a core element of an EVMPD product record?
- Individual patient identifiers from adverse event reports
- Pharmaceutical form and strength
- Active substance and INN
- Marketing authorization number
Correct Answer: Individual patient identifiers from adverse event reports
Q14. How does EVMPD relate to ISO IDMP and the SPOR program?
- EVMPD data models are being aligned with ISO IDMP standards via the SPOR implementation
- EVMPD will replace ISO IDMP globally
- SPOR is unrelated and only concerns clinical trials
- ISO IDMP mandates clinical endpoints for EVMPD
Correct Answer: EVMPD data models are being aligned with ISO IDMP standards via the SPOR implementation
Q15. Which identifier links a product record to its marketing authorization in EVMPD?
- Marketing authorization number (MA number)
- Batch number
- Patient insurance number
- Manufacturer internal SKU only
Correct Answer: Marketing authorization number (MA number)
Q16. Is EVMPD intended to be global or EU-focused?
- EU-focused for products authorised in the European Economic Area
- Global registry covering every marketed medicine worldwide
- Only for medicines in clinical trials outside the EU
- Only for veterinary products
Correct Answer: EU-focused for products authorised in the European Economic Area
Q17. Which substance naming convention is commonly used in EVMPD to identify active ingredients?
- International Nonproprietary Name (INN)
- Local pharmacy nickname
- Manufacturer’s internal code
- Proprietary marketing tagline
Correct Answer: International Nonproprietary Name (INN)
Q18. Does EVMPD include packaging and pack-size details for medicinal products?
- Yes, packaging type and pack sizes are captured to support product identification
- No, packaging is never recorded anywhere in pharmacovigilance
- Only batch expiry dates are stored, not pack sizes
- Packs are described only by manufacturers in brochures
Correct Answer: Yes, packaging type and pack sizes are captured to support product identification
Q19. Which type of reports directly use EVMPD identifiers for analysis?
- Individual Case Safety Reports (ICSRs) and Periodic Safety Update Reports (PSURs)
- Annual financial audit reports
- Clinical protocol deviation reports only
- Marketing campaign performance reports
Correct Answer: Individual Case Safety Reports (ICSRs) and Periodic Safety Update Reports (PSURs)
Q20. Which organization is responsible for assigning ATC codes that appear in EVMPD records?
- WHO Collaborating Centre for Drug Statistics Methodology
- European Commission DG SANTE
- International Conference on Harmonisation (ICH)
- National pharmacies only
Correct Answer: WHO Collaborating Centre for Drug Statistics Methodology
Q21. Are batch numbers and expiry dates core parts of EVMPD product records?
- No; batch/expiry are typically recorded in case reports or batch-release systems, not EVMPD product master records
- Yes; EVMPD stores every individual batch and expiry for all products
- Only expiry dates are stored, never batch numbers
- EVMPD stores batch numbers only for biologicals
Correct Answer: No; batch/expiry are typically recorded in case reports or batch-release systems, not EVMPD product master records
Q22. Which format is commonly used to submit EVMPD product data electronically?
- Structured XML submissions following EMA schemas
- Handwritten letters to the EMA
- Unstructured PDF product brochures only
- Audio recordings of product managers
Correct Answer: Structured XML submissions following EMA schemas
Q23. What does SPOR stand for in the context of EMA data management?
- Substance, Product, Organisation, Referential
- Safety, Pharmacology, Outcomes, Reports
- Standardized Product Order Registry
- Single Pharmaceutical Online Repository
Correct Answer: Substance, Product, Organisation, Referential
Q24. Which role best describes who can access EVMPD product information for regulatory review?
- EMA and national competent authorities, and authorized MAHs
- General public with no credentials
- Only pharmacists in hospitals without EMA approval
- Third-party marketers for commercial use
Correct Answer: EMA and national competent authorities, and authorized MAHs
Q25. How are excipients treated within EVMPD product records?
- Excipients and their roles can be captured as part of substance composition
- Excipients are never recorded in any regulatory dataset
- Only impurities are listed, not excipients
- Excipients are replaced by ingredient codes from at-random lists
Correct Answer: Excipients and their roles can be captured as part of substance composition
Q26. Which of the following best describes EVMPD record lifecycle management?
- Records have statuses (e.g., active, withdrawn) and are versioned to track changes
- Records are immutable and cannot be changed once created
- Records are deleted every month and re-uploaded
- Only one global administrator may ever edit records
Correct Answer: Records have statuses (e.g., active, withdrawn) and are versioned to track changes
Q27. Can EVMPD be used to find the authorized routes of administration for a medicine?
- Yes; route of administration is a standard attribute in product records
- No; routes are not relevant for pharmacovigilance
- Routes are recorded only in clinical trial registries
- Routes are inferred from packaging images only
Correct Answer: Yes; route of administration is a standard attribute in product records
Q28. Which of the following most improves interoperability between EVMPD and other regulatory systems?
- Use of unique identifiers (MPID) and standardized vocabularies
- Using only local free-text descriptions for products
- Storing data in proprietary binary formats
- Relying on informal email exchanges for updates
Correct Answer: Use of unique identifiers (MPID) and standardized vocabularies
Q29. Is EVMPD intended to replace marketing authorization dossiers?
- No; it complements regulatory dossiers by maintaining structured product metadata for safety reporting
- Yes; EVMPD is the substitute for the full marketing dossier
- EVMPD is only for pricing dossiers
- EVMPD is a replacement for GMP certificates
Correct Answer: No; it complements regulatory dossiers by maintaining structured product metadata for safety reporting
Q30. How many core ISO IDMP standards broadly underpin the identification of medicinal products and substances?
- Five core ISO IDMP standards
- Two core ISO IDMP standards
- Ten core ISO IDMP standards
- Only one ISO standard exists for all needs
Correct Answer: Five core ISO IDMP standards
